Andere talen Evofem Biosciences, Inc.

Aandelen

EVFM

US30048L3024

Beurs gesloten - OTC Markets Andere beurzen 21:59:19 22-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,0159 ^USD	+3,25%		+6,00%	-75,16%

27/03	Evofem Biosciences, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
27/03	Evofem Biosciences, Inc. Rapporteert winstresultaten voor het vierde kwartaal dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Evofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO	18/04
Evofem Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Evofem Reports $18.2 million of Phexxi Net Product Sales in 2023	27/03
Evofem Biosciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	27/03
Evofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal	20/03
Evofem Biosciences - For Women Using GLP-1 Receptor Agonists who take Oral Birth Control Pills, Hormone-Free Phexxi Contraceptive Gel is a Logical Solution to Help Prevent Unintended Pregnancy	08/03
Washington State HCA Removes Prior Authorization for Hormone-Free "In the Moment" Contraceptive PHEXXI Ahead of Huskies vs. Wolverines Championship Game	08/01
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLI	19/12
EVOFEM BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Evofem Biosciences, Inc. - EVFM	18/12
North American Morning Briefing : Dow Set For New -2-	14/12
Aditxt, Inc. Enters into Definitive Agreement to Acquire Evofem Biosciences, Inc., Creator of Phexxi, the First and Only FDA-Approved Hormone-Free Contraceptive Gel	13/12
Shareholder Alert: Ademi LLP investigates whether Evofem Biosciences, Inc. has obtained a Fair Price in its transaction with Aditxt	12/12
EVFM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Evofem Biosciences, Inc. Is Fair to Shareholders	12/12
Evofem Biosciences Announces Financial Results for the Third Quarter of 2023	14/11
Evofem Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
Evofem Biosciences : Presentation	01/11
OTC Stocks News-Based Catalyst Watchlist (IMRFF, BLFR, NILIF, EVFM)	25-10-23
Evofem Biosciences : EVFM at a Glance	24-10-23
Evofem Biosciences, Inc. Provides Sales Guidance for the Third Quarter of 2023	24-10-23
Evofem Biosciences Announces Preliminary Results for the Third Quarter of 2023	24-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Evofem Biosciences, Inc.

Aandelen

EVFM

US30048L3024

Andere talen

Filters